Egrifta (tesamorelin) Approval

FDA approved Egrifta (tesamorelin for injection) to reduce excess abdominal fat in HIV-infected patients with lipodystrophy.

Not legal or medical advice.

This page is for informational purposes only. Always verify the current official source or consult a qualified professional before making compliance, prescribing, purchasing, or clinical decisions. Read full disclaimer.